Research Articles
The End of Acquired Immunodeficiency Syndrome in Singapore: Are We There Yet?
Exploring Singapore's progress toward ending AIDS as a public health threat by 2030 through scientific advances, public health strategies, and remaining challenges.
A New Hope for Tough-to-Treat HIV: The Long-Term Power of Ibalizumab
Exploring the five-year success of ibalizumab for multidrug-resistant HIV patients, with data visualizations and clinical trial insights.
The Surprising Side Effect: Can Switching HIV Drugs Curb Weight Gain?
A clinical trial challenges a simple solution to a complex problem in modern HIV care. Learn about the SWITCH trial results on managing integrase inhibitor-related weight gain.
The ICU Lifeline: Mastering the ART of Saving Patients with HIV
Explore the advanced medical approaches for caring for critically ill HIV patients in the ICU, focusing on antiretroviral therapy timing and evidence-based practices.
How Tiny Genetic Variations Shape the Course of HIV Infection
Exploring how single nucleotide polymorphisms in HIV-1 and SIV alter transcription factor binding and influence viral pathogenesis, disease progression, and neurocognitive impairment.
Revolutionizing HIV Treatment: How Same-Day Start Therapy is Changing Lives
Discover how Rapid Start Antiretroviral Therapy (RSA) is transforming HIV care by initiating treatment on the same day as diagnosis, dramatically accelerating viral suppression rates.
Fewer Pills, Same Results: The DYAD Study Simplifies HIV Treatment
Groundbreaking clinical trial comparing two-drug vs three-drug HIV regimens for virologically suppressed patients
The Invisible Arms Race: Key Reports from the 2006 HIV Drug Resistance Workshop
Analysis of the XV International HIV Drug Resistance Workshop findings on HIV drug resistance patterns, transmission trends, and emerging treatments.
The Silent Setback: Unraveling Why HIV Treatments Sometimes Fail
Exploring the hidden factors behind HIV treatment failure in resource-poor communities and the systemic challenges that undermine antiretroviral therapy success.
The Final Defense: Inside the World of Third-Line HIV Therapy
Exploring the profile of patients undergoing third-line antiretroviral therapy for HIV treatment, including drug resistance, treatment challenges, and scientific breakthroughs.